Healthcare & Life Sciences
Oxyrane
United Kingdomwww.oxyrane.com
Oxyrane is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
1
Investors
About Oxyrane
Based in the United Kingdom, Oxyrane is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Oxyrane is a biopharmaceutical company focused on developing enzyme replacement therapies (ERTs) for lysosomal storage diseases, particularly those affecting the central nervous system. The company utilizes a proprietary glyco-engineering yeast platform to produce enzymes with enhanced cellular uptake and efficacy.
Explore Oxyrane's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.